Valuation: Guerbet

Market Cap 82.8M 92.33M 76.31M 69.3M 131M 8.66B 135M 914M 364M 4.64B 347M 339M 14.66B P/E 2026 *
-5.16x
P/E 2027 * 7.06x
Enterprise Value 470M 524M 433M 393M 745M 49.14B 765M 5.19B 2.07B 26.33B 1.97B 1.93B 83.23B EV / Sales 2026 *
0.61x
EV / Sales 2027 * 0.6x
Free-Float
36.58%
Yield 2026 *
3.79%
Yield 2027 * 3.54%
1 day+0.91%
1 week+6.39%
Current month+1.37%
1 month+3.26%
3 months-19.57%
6 months-35.47%
Current year-53.43%
1 week 6.06
Extreme 6.06
6.66
1 month 5.8
Extreme 5.8
6.91
Current year 5.8
Extreme 5.8
15.12
1 year 5.8
Extreme 5.8
18.26
3 years 5.8
Extreme 5.8
40.25
5 years 5.8
Extreme 5.8
40.25
10 years 5.8
Extreme 5.8
90.64
Manager TitleAgeSince
Chief Executive Officer - 02/02/2026
Chief Executive Officer - 22/09/2025
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 44 29/05/2015
Director/Board Member 50 19/05/2017
Director/Board Member 52 22/11/2023
Date Insider Type Main position Quantity % Market Cap. Importance
6/8/26 Buy

Director

1,185 0.0094%
5/8/26 Buy

Director

5,027 0.0398%
4/8/26 Buy

Director

3,788 0.0300%
Change 5-day change 1-year change 3-year change Capi.($)
+0.91%+6.39%-56.98%-61.19% 92.33M
-0.48%+2.84%+24.61%+60.16% 266B
+0.42%+2.61%+11.81%+19.85% 166B
-2.28%+2.11%-21.90%+62.18% 156B
+1.54%+2.76%-55.70%-13.30% 64.79B
-0.67%+9.27%+23.70%+61.98% 59.81B
+0.68%-3.52%-2.61%-8.75% 53.3B
-1.27%+1.38%+21.54%+63.99% 50.15B
-0.28%+0.77%+3.31%+85.09% 49.47B
-0.25%+3.40%+26.28%+85.81% 46.72B
Average -0.17%+3.22%-2.59%+35.58% 91B
Weighted average by Cap. -0.45%+3.00%+5.73%+46.91%

Financials

2026 *2027 *
Net sales 769M 857M 709M 644M 1.22B 80.38B 1.25B 8.48B 3.38B 43.07B 3.22B 3.15B 136B 795M 887M 733M 666M 1.26B 83.16B 1.3B 8.78B 3.5B 44.55B 3.33B 3.26B 141B
Net income -51.5M -57.43M -47.46M -43.1M -81.58M -5.38B -83.85M -568M -226M -2.88B -216M -211M -9.12B 8.2M 9.14M 7.56M 6.86M 12.99M 857M 13.35M 90.48M 36.05M 459M 34.32M 33.59M 1.45B
Net Debt 387M 432M 357M 324M 613M 40.49B 631M 4.27B 1.7B 21.69B 1.62B 1.59B 68.57B 391M 435M 360M 327M 619M 40.83B 636M 4.31B 1.72B 21.88B 1.63B 1.6B 69.15B
Projected Income Statement - Annual - Guerbet
Logo Guerbet
Guerbet is a European leader in producing and selling contrast products for medical imaging. The group's products make it possible to visualize different organs and the lymphatic and vascular systems of the human body by making them opaque. Net sales break down by product family as follows: - X-ray imaging products (54.4%); - MRI products (32.1%); - other (13.5%): contrast products for echography and nuclear medicine, fine chemicals products. At the end of 2024 the group had 8 production sites located in France (4), the United States (2), Ireland and Brazil. Net sales are distributed geographically as follows: Europe/Middle East/Africa (43.8%), Americas (29.7%) and Asia (26.5%).
Employees
2,700
Date Price Change Volume
11/11/26 EUR 6.660 +0.91% 727
10/11/26 EUR 6.600 +1.54% 7,503
09/11/26 EUR 6.500 +0.78% 7,727
06/11/26 EUR 6.450 +5.74% 25,463
05/11/26 EUR 6.100 -2.56% 16,528
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - Guerbet
Sell
Consensus
Buy
Mean consensus
UNDERPERFORM
Number of Analysts
2
Last Close Price
6.600EUR
Average target price
7.650EUR
Spread / Average Target
+15.91%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Guerbet